NO20026122L - Terapeutisk preparat mot angstneurose eller depresjon og piperazinderivater - Google Patents

Terapeutisk preparat mot angstneurose eller depresjon og piperazinderivater

Info

Publication number
NO20026122L
NO20026122L NO20026122A NO20026122A NO20026122L NO 20026122 L NO20026122 L NO 20026122L NO 20026122 A NO20026122 A NO 20026122A NO 20026122 A NO20026122 A NO 20026122A NO 20026122 L NO20026122 L NO 20026122L
Authority
NO
Norway
Prior art keywords
depression
piperazine derivatives
therapeutic preparation
anxiety neurosis
neurosis
Prior art date
Application number
NO20026122A
Other languages
English (en)
Norwegian (no)
Other versions
NO20026122D0 (no
Inventor
Atsuro Nakazato
Shigeyuki Chaki
Taketoshi Okubo
Shin-Ichi Ogawa
Takaaki Ishii
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of NO20026122D0 publication Critical patent/NO20026122D0/no
Publication of NO20026122L publication Critical patent/NO20026122L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20026122A 2000-06-27 2002-12-19 Terapeutisk preparat mot angstneurose eller depresjon og piperazinderivater NO20026122L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000192856 2000-06-27
PCT/JP2001/005524 WO2002000259A1 (fr) 2000-06-27 2001-06-27 Agent therapeutique contre l'anxiete nevrotique ou la depression et derive de piperazine

Publications (2)

Publication Number Publication Date
NO20026122D0 NO20026122D0 (no) 2002-12-19
NO20026122L true NO20026122L (no) 2003-02-25

Family

ID=18691931

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20026122A NO20026122L (no) 2000-06-27 2002-12-19 Terapeutisk preparat mot angstneurose eller depresjon og piperazinderivater

Country Status (22)

Country Link
US (1) US6949552B2 (fr)
EP (1) EP1295608A4 (fr)
JP (1) JP5002881B2 (fr)
KR (1) KR20030013470A (fr)
CN (1) CN1438897A (fr)
AU (2) AU2001266342B2 (fr)
BG (1) BG107371A (fr)
BR (1) BR0111976A (fr)
CA (1) CA2413506A1 (fr)
CZ (1) CZ20024165A3 (fr)
EA (2) EA200500087A1 (fr)
EE (1) EE200200717A (fr)
HR (1) HRP20030056A2 (fr)
HU (1) HUP0301719A2 (fr)
IL (1) IL153706A0 (fr)
MX (1) MXPA02012707A (fr)
NO (1) NO20026122L (fr)
NZ (1) NZ523800A (fr)
PL (1) PL360286A1 (fr)
SK (1) SK18322002A3 (fr)
WO (1) WO2002000259A1 (fr)
ZA (1) ZA200210386B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK18322002A3 (sk) 2000-06-27 2003-09-11 Taisho Pharmaceutical Co., Ltd. Terapeutický prostriedok proti úzkosti alebo depresii a piperazínové deriváty
US7354923B2 (en) 2001-08-10 2008-04-08 Palatin Technologies, Inc. Piperazine melanocortin-specific compounds
US7456184B2 (en) 2003-05-01 2008-11-25 Palatin Technologies Inc. Melanocortin receptor-specific compounds
US7655658B2 (en) 2001-08-10 2010-02-02 Palatin Technologies, Inc. Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compounds
AU2002331064B2 (en) 2001-08-10 2007-08-23 Palatin Technologies, Inc. Peptidomimetics of biologically active metallopeptides
US7732451B2 (en) 2001-08-10 2010-06-08 Palatin Technologies, Inc. Naphthalene-containing melanocortin receptor-specific small molecule
US7718802B2 (en) 2001-08-10 2010-05-18 Palatin Technologies, Inc. Substituted melanocortin receptor-specific piperazine compounds
US20060084657A1 (en) * 2001-12-21 2006-04-20 Atsuro Nakazato Piperazine derivative
US7968548B2 (en) * 2003-05-01 2011-06-28 Palatin Technologies, Inc. Melanocortin receptor-specific piperazine compounds with diamine groups
US7727991B2 (en) 2003-05-01 2010-06-01 Palatin Technologies, Inc. Substituted melanocortin receptor-specific single acyl piperazine compounds
US7727990B2 (en) 2003-05-01 2010-06-01 Palatin Technologies, Inc. Melanocortin receptor-specific piperazine and keto-piperazine compounds
US7419980B2 (en) * 2003-10-14 2008-09-02 Wyeth Fused-aryl and heteroaryl derivatives and methods of their use
US7491723B2 (en) 2003-10-14 2009-02-17 Wyeth Alkanol and cycloalkanol-amine derivatives and methods of their use
US7709484B1 (en) 2004-04-19 2010-05-04 Palatin Technologies, Inc. Substituted melanocortin receptor-specific piperazine compounds
RU2413510C2 (ru) * 2005-04-04 2011-03-10 Такеда Фармасьютикал Компани Лимитед Профилактический или терапевтический агент против депрессии или тревожного расстройства
US20070021433A1 (en) 2005-06-03 2007-01-25 Jian-Qiang Fan Pharmacological chaperones for treating obesity
US7834017B2 (en) 2006-08-11 2010-11-16 Palatin Technologies, Inc. Diamine-containing, tetra-substituted piperazine compounds having identical 1- and 4-substituents
US20080108574A1 (en) * 2006-09-27 2008-05-08 Braincells, Inc. Melanocortin receptor mediated modulation of neurogenesis
EP2072050A1 (fr) * 2007-12-21 2009-06-24 Santhera Pharmaceuticals (Schweiz) AG Composés à effet anti-émétique
EP2475643A1 (fr) * 2009-09-07 2012-07-18 Vifor (International) Ag Nouveaux antagonistes éthanediamine de l'hepcidine
US8609672B2 (en) 2010-08-27 2013-12-17 University Of The Pacific Piperazinylpyrimidine analogues as protein kinase inhibitors
WO2012100342A1 (fr) 2011-01-27 2012-08-02 Université de Montréal Pyrazolopyridine et dérivés de pyrazolopyrimidine en tant que modulateurs du récepteur de la mélanocortine-4

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1317053A (fr) * 1961-03-17 1963-02-01 Soc Ind Fab Antibiotiques Sifa Nouveaux dérivés de la pipérazine, et procédé de préparation
CA918659A (en) * 1969-07-31 1973-01-09 Yoshitomi Pharmaceutical Industries 11-(4-substituted-1-piperazinyl)-dibenzo (b,f) (1,4) thiazepines
FR2601364B1 (fr) * 1986-07-09 1988-10-21 Adir Nouveaux derives de la piperazine dione-2,6, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
GB9021453D0 (en) 1990-10-03 1990-11-14 Wyeth John & Brother Ltd Piperazine derivatives
JPH0641071A (ja) * 1991-09-06 1994-02-15 Taisho Pharmaceut Co Ltd インドール酢酸エステル誘導体
GB9200293D0 (en) 1992-01-08 1992-02-26 Wyeth John & Brother Ltd Piperazine derivatives
SE9700620D0 (sv) 1997-02-21 1997-02-21 Wapharm Ab Cykliska peptider med selektivitet för MSH-receptor subtyper
WO1999064002A1 (fr) 1998-06-11 1999-12-16 Merck & Co., Inc. Derives de spiropiperidine en tant qu'agonistes des recepteurs de la melanocortine
SK18322002A3 (sk) 2000-06-27 2003-09-11 Taisho Pharmaceutical Co., Ltd. Terapeutický prostriedok proti úzkosti alebo depresii a piperazínové deriváty

Also Published As

Publication number Publication date
CZ20024165A3 (cs) 2004-03-17
SK18322002A3 (sk) 2003-09-11
EE200200717A (et) 2004-08-16
BR0111976A (pt) 2003-12-09
BG107371A (bg) 2003-08-29
IL153706A0 (en) 2003-07-06
WO2002000259A1 (fr) 2002-01-03
EP1295608A4 (fr) 2004-03-31
JP5002881B2 (ja) 2012-08-15
NZ523800A (en) 2005-02-25
US6949552B2 (en) 2005-09-27
MXPA02012707A (es) 2003-04-25
PL360286A1 (en) 2004-09-06
EA200500087A1 (ru) 2005-06-30
EP1295608A1 (fr) 2003-03-26
CA2413506A1 (fr) 2002-12-20
NO20026122D0 (no) 2002-12-19
US20030186992A1 (en) 2003-10-02
EA005737B1 (ru) 2005-06-30
ZA200210386B (en) 2004-02-10
HUP0301719A2 (hu) 2003-09-29
EA200300071A1 (ru) 2003-06-26
KR20030013470A (ko) 2003-02-14
HRP20030056A2 (en) 2005-02-28
AU6634201A (en) 2002-01-08
CN1438897A (zh) 2003-08-27
AU2001266342B2 (en) 2005-01-27

Similar Documents

Publication Publication Date Title
NO20026122L (no) Terapeutisk preparat mot angstneurose eller depresjon og piperazinderivater
EE200200656A (et) Ravis kasutatavad tropaani derivaadid
DK1578755T3 (da) Phosphonooxyguinalinderivater og deres farmaceutiske anvendelse
NO20030596D0 (no) Benzimidazolderivater, deres fremstilling og terapeutiske anvendelse
NO20021400D0 (no) Terapeutiske konazolinderivater
DK1419150T3 (da) 1-Phenylsulfonyl-1,3-dihydro-2H-indol-2-on-derivater, deres fremstilling og deres terapeutiske anvendelse
NO20025357D0 (no) Antranylamider og deres anvendelse som legemidler
DK1353919T3 (da) Hidtil ukendte quinuclidinderivater og medicinale sammensætninger indeholdende samme
DK1161434T3 (da) Pyridopyranoazepinderivater, deres fremstilling og terapeutiske anvendelse
NO20031838D0 (no) Benzokazinonderivater, deres fremstilling og anvendelse
NO20025158D0 (no) Lipidpreparat og anvendelse derav
NO20034413L (no) Beta-karbolinderivater og deres farmasöytiske anvendelse mot depresjon og angst
DK1043307T3 (da) 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse
IS6723A (is) 10-arýl-11H-bensó[b]flúorenafleiður og hliðstæðurtil lyfjanotkunar
DK1387838T3 (da) Cyanoanthranylamid-derivater og deres anvendelse som lægemidler
DK1525193T3 (da) Acylaminothiazolderivater, deres fremstilling og deres terapeutiske anvendelse
NO20030156D0 (no) Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav
NO20030547L (no) Azabicykliske derivater og deres terapeutiske anvendelse
NO20033120D0 (no) 2-arylimino-2,3-dihydrotiazolderivater, fremgangsmater for fremstilling derav og terapeutisk anvendelse derav
NO20024107L (no) Tienopyridin derivater, deres fremstilling og anvendelse
DE60117096D1 (de) Dihydroindol- und tetrahydrochinolinderivate
EE200300466A (et) Püridoindolooni derivaatide kasutamine ravimite valmistamiseks
NO20001782D0 (no) 3-amino-3-arylpropan-1-ol-derivater, deres fremstilling og anvendelse
DK1458721T3 (da) 3-heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-b]indol-1-carbox-amidderivater, deres fremstilling og terapeutisk anvendelse
NO20010630L (no) Krummet trapp og trappetrinn for krummet trapp

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application